Mass General Hospital

Harvard Medical School

Welcome to the MGH Center for Women’s Mental Health


Welcome to The Ammon-Pinizzotto Center for Women’s Mental Health at MGH. Our Center, established in 1989, has been renamed following the generous gift from Carol Ammon and Dr. Marie Pinizzotto. These resources will be used to realize the overarching mission of the Center.

This website provides a range of current information including discussion of new research findings in women’s mental health and how such investigations inform day-to-day clinical practice. Despite the growing number of studies being conducted in women’s health, the clinical implications of such work are frequently controversial, leaving patients with questions regarding the most appropriate path to follow. Providing these resources to patients and their doctors so that individual clinical decisions can be made in a thoughtful and collaborative fashion dovetails with the mission of our Center.

The National Pregnancy Registry for Atypical Antipsychotics: All pregnant women ages 18-45 are eligible to enroll in the registry. We are currently seeking both controls and those being treated with one or more of the following atypical antipsychotics:
  • Abilify (aripiprazole)
  • Clozaril (clozapine)
  • Fanapt (iloperidone)
  • Geodon (ziprasidone)
  • Invega (paliperidone)
  • Latuda (lurasidone)
  • Risperdal (risperidone)
  • Saphris (asenapine)
  • Seroquel (quetiapine)
  • Zyprexa (olanzapine)
Register now by calling 1-866-961-2388 and help make the future better for many other women just like you. This study will involve 3 brief phone interviews over an 8-month period. The National Pregnancy Registry for Atypical Antipsychotics is dedicated to evaluating the safety of atypical antipsychotic medications that may be taken by women during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders. The primary goal of this Registry is to determine the frequency of major malformations, such as heart defects, cleft lip, or neural tube defects, in infants exposed to atypical antipsychotics during pregnancy. For more information, please call 1-866-961-2388.

The MGH Center for Women’s Mental Health

Perinatal and Reproductive Psychiatry Program

Simches Research Building

185 Cambridge St Suite 2200

Boston, MA 02114


To make an appointment:

Massachusetts General Hospital Clinical Program: (617) 724-7792

Location of appointments: 

Wang Ambulatory Care Center, Massachusetts General Hospital

15 Parkman St., Floor 8

Boston, MA 02114-3117 

Latest News from our Blog

  • Are Women with Bipolar Disorder at Risk of Illness After Miscarriage?

    February 12, 2016


    Women with bipolar disorder are at significant risk for recurrent illness during the postpartum period.  After miscarriage, an event which is associated with both hormonal changes and psychological xx, is the risk for recurrent illness also increased? This question was addressed by researchers with a retrospective review of 1,283 women with “broadly defined bipolar disorder”.  Rates ...

    Read more
  • Urge Your Reps to Sponsor Legislation Supporting the Treatment of Maternal Depression

    February 11, 2016

    Credit: Depressed Mother from Wikimedia Commons

    There is some legislation being considered in the House and Senate that all of you — health care providers, advocates, women and their families and friends — should know about: H.R. 3235: Bringing Postpartum Depression Out of the Shadows Act of 2015 S. 2311: Bringing Postpartum Depression Out of the Shadows Act of 2015 House of Representatives Bill #HR3235 ...

    Read more
  • February Issue of AJP Devoted to Maternal Mental Health

    February 10, 2016

    ajp cover

    The February issue of the American Journal of Psychiatry is devoted to maternal mental health.  Several very interesting articles to add to your reading list. Maternal Defense Mechanisms Influence Infant Developmen Christopher Perry 173(2), pp. 99–100 Mothers, Babies, Depression, and Medications: Understanding the Complex Interplay of Illness and Treatment on Neonatal Symptoms Linda H. Chaudron 173(2), pp. 101–102 Risk of Postpartum Relapse ...

    Read more
  • Guest Post: Dr. Anna Glezer on the Emotional Side Effects of Infertility Medications

    February 9, 2016


    This week we are pleased to have a guest post from Dr. Anna Glezer.  She is a perinatal psychiatrist practicing at the University of California San Francisco and the founder of Mind Body Pregnancy, a new online resource uniquely focusing on all topics related to the emotional health of women during their reproductive years.   Infertility, affecting ...

    Read more
  • In Brief: Menopausal Symptoms More Severe in Sedentary Women

    February 4, 2016


    According to a recent study article published online in Menopause, having a sedentary lifestyle significantly affects the severity of perimenopausal symptoms.  This study included more than 6000 women aged 40 to 59 years who received care at urban health clinics across 11 Latin American countries. Women who exercised fewer than three times per week reported more severe menopause symptoms than those ...

    Read more
  • CDC Calls for Increased Research into the Safety of Antidepressants During Pregnancy

    February 2, 2016

    Baby Belly from Wikimedia Commons

    Something is happening.  The issue of perinatal depression is spending a lot of time in the media spotlight these days.  But rather than focusing on the risks of medications used during pregnancy (the usual headline grabber), these reports highlight the high prevalence of mood and anxiety disorders in pregnancy and postpartum women and the need ...

    Read more

Read more from our Blog